| scholarly article | Q13442814 |
| P50 | author | Jeffrey R Curtis | Q87706464 |
| Elizabeth Delzell | Q114560702 | ||
| P2093 | author name string | Hong Cheng | |
| Huifeng Yun | |||
| Meredith Kilgore | |||
| Kenneth Saag | |||
| David Fram | |||
| William Dumouchel | |||
| P2860 | cites work | Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials | Q28213612 |
| Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting | Q30881243 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas | Q34570463 | ||
| Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 | ||
| Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects | Q36531491 | ||
| Long-term risk of ischemic stroke associated with rofecoxib | Q36773675 | ||
| Novel statistical tools for monitoring the safety of marketed drugs | Q36835511 | ||
| Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration | Q44955650 | ||
| Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications | Q44960512 | ||
| Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study | Q48521294 | ||
| Paradoxical relations of drug treatment with mortality in older persons. | Q52935565 | ||
| Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction | Q57260454 | ||
| Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk | Q79273482 | ||
| P433 | issue | 9 | |
| P921 | main subject | algorithm | Q8366 |
| data mining | Q172491 | ||
| P304 | page(s) | 969-975 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Medical Care | Q15762119 |
| P1476 | title | Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example | |
| P478 | volume | 46 |
| Q35878060 | Amiodarone-associated optic neuropathy: a critical review. |
| Q38533029 | Detection of Drug-Drug Interactions Inducing Acute Kidney Injury by Electronic Health Records Mining |
| Q33723762 | Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases |
| Q43432728 | Disproportionality methods for pharmacovigilance in longitudinal observational databases |
| Q30706858 | Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic |
| Q37970928 | Emergency department triaging of admitted stroke patients--a Bayesian Network analysis. |
| Q30876081 | Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection |
| Q43577539 | Fractures and mortality in relation to different osteoporosis treatments |
| Q36914069 | Good Signal Detection Practices: Evidence from IMI PROTECT |
| Q38786754 | Hierarchical Models for Multiple, Rare Outcomes Using Massive Observational Healthcare Databases |
| Q34360288 | Massive parallelization of serial inference algorithms for a complex generalized linear model |
| Q37964440 | Methods for observational post-licensure medical product safety surveillance |
| Q38793916 | Methods for safety signal detection in healthcare databases: a literature review |
| Q38078815 | Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture? |
| Q33818302 | Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies. |
| Q46608418 | Safety surveillance of longitudinal databases: methodological considerations |
| Q40075147 | Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database |
| Q30706851 | Signal detection and monitoring based on longitudinal healthcare data |
| Q88529836 | Sources of Safety Data and Statistical Strategies for Design and Analysis: Postmarket Surveillance |
| Q54981091 | Statistical Power for Postlicensure Medical Product Safety Data Mining. |
| Q30379316 | Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature. |
Search more.